Impact of Implementing 100% Rapid Review as a Quality Control Tool in Cervical Cytology
Rattachement africain : br. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
OBJECTIVE: We aimed to evaluate the impact of implementing 100% rapid review (100% RR) as a quality control tool in cervical smear cytology. DESIGN: A cross-sectional study was conducted in which cytology findings, false-negative results, and quality indicators were evaluated. The variables were analyzed in 2004, the year in which 100% RR was implemented, and again in 2013, i.e., 10 years on. RESULTS: Detection of atypical squamous cells of undetermined significance (ASC-US) increased from 0.90% in 2004 to 2.47% in 2013 by routine screening. Detection of atypical squamous cells, cannot exclude a high-grade squamous intraepithelial lesion (ASC-H) increased from 13.33% in 2004 to 36.27% in 2013 by 100% RR. Detection of high-grade squamous intraepithelial lesion (HSIL) increased from 0.64% in 2004 to 4.29% in 2013 by routine screening, and increased from 0% in 2004 to 19.61% in 2013 by 100% RR. There was a significant increase (p = 0.00001) in the identification of false-negative results of ASC-US, low-grade squamous intraepithelial lesion, ASC-H, HSIL, and atypical glandular cells. All quality indicators had increased in 2013 when compared to 2004 results. CONCLUSIONS: Ten years after the implementation of the 100% RR method, improvements were found in the detection of atypia and precursor lesions and in quality indicators.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Impact of Implementing 100% Rapid Review as a Quality Control Tool in Cervical Cytology
- Date Crossref
- 01/01/2018
- Éditeur
- S. Karger AG
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Universidade Federal de Goiás pays non établi dans la noticeUniversité ou école supérieure
-
Pontifícia Universidade Católica de Goiás pays non établi dans la noticeUniversité ou école supérieure
-
School of Pharmacy pays non établi dans la noticeUniversité ou école supérieure
-
Pontifical Catholic University of Goiás pays non établi dans la noticeUniversité ou école supérieure
Universidade Federal de Goiás, Pontifícia Universidade Católica de Goiás et School of Pharmacy, avec 1 autre affiliation.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.